34953508|t|New Drug Update: Dostarlimab, Loncastuximab Tesirine, and Aducanumab.
34953508|a|Three new drugs are presented: dostarlimab, loncastuximab tesirine, and aducanumab. Product information, clinical trials, and recommendations are provided. Dostarlimab (Jemperli ) is FDA-indicated for the treatment of adult patients with mismatch repair deficient (dMMR - an abnormality that affects DNA repair) recurrent or advanced endometrial cancer (EC). Loncastuximab tesirine (Zynlonta ) is FDA-indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, DLBCL arising from low grade lymphoma, and high-grade B-cell lymphoma. Aducanumab (Aduhelm ) is FDA-indicated for the treatment of Alzheimer's disease. It is an amyloid beta-directed antibody developed by Biogen of Cambridge, Massachusetts. This indication was approved on June 7, 2021, under the accelerated approval based on the reduction in amyloid beta plaques in patients treated with the drug.
34953508	17	28	Dostarlimab	Chemical	MESH:C000719628
34953508	30	52	Loncastuximab Tesirine	Chemical	MESH:C000710749
34953508	58	68	Aducanumab	Chemical	MESH:C000600266
34953508	101	112	dostarlimab	Chemical	MESH:C000719628
34953508	114	136	loncastuximab tesirine	Chemical	MESH:C000710749
34953508	142	152	aducanumab	Chemical	MESH:C000600266
34953508	226	237	Dostarlimab	Chemical	MESH:C000719628
34953508	294	302	patients	Species	9606
34953508	308	323	mismatch repair	Disease	MESH:C536928
34953508	335	339	dMMR	Disease	
34953508	404	422	endometrial cancer	Disease	MESH:D016889
34953508	424	426	EC	Disease	MESH:D016889
34953508	429	451	Loncastuximab tesirine	Chemical	MESH:C000710749
34953508	453	461	Zynlonta	Chemical	MESH:C000710749
34953508	508	516	patients	Species	9606
34953508	551	566	B-cell lymphoma	Disease	MESH:D016393
34953508	622	651	diffuse large B-cell lymphoma	Disease	MESH:D016403
34953508	653	658	DLBCL	Disease	MESH:D016403
34953508	685	690	DLBCL	Disease	MESH:D016403
34953508	714	722	lymphoma	Disease	MESH:D008223
34953508	739	754	B-cell lymphoma	Disease	MESH:D016393
34953508	756	766	Aducanumab	Chemical	MESH:C000600266
34953508	768	775	Aduhelm	Chemical	MESH:C000600266
34953508	816	835	Alzheimer's disease	Disease	MESH:D000544
34953508	846	858	amyloid beta	Gene	351
34953508	1029	1049	amyloid beta plaques	Disease	MESH:D058225
34953508	1053	1061	patients	Species	9606
34953508	Negative_Correlation	MESH:C000710749	MESH:D016403
34953508	Negative_Correlation	MESH:C000719628	MESH:D016889
34953508	Negative_Correlation	MESH:C000710749	MESH:D016393
34953508	Negative_Correlation	MESH:C000600266	MESH:D058225
34953508	Negative_Correlation	MESH:C000600266	MESH:D000544
34953508	Negative_Correlation	MESH:C000600266	351
34953508	Association	MESH:C000719628	MESH:C536928
34953508	Negative_Correlation	MESH:C000710749	MESH:D008223
34953508	Association	MESH:D000544	351

